Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01538056 · ClinicalTrials.gov registry record · NA

Physician Modified Endovascular Grafts

A NA study of Abdominal Aortic Aneurysms, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT01538056: Recruiting NA study of Abdominal Aortic Aneurysms, sponsored by University of Washington.

NCT01538056 is a NA study of Abdominal Aortic Aneurysms that is actively recruiting participants, run by University of Washington. The registered enrollment target is 500 participants, above the 103-participant average among 5 other Abdominal Aortic Aneurysms trials with a reported enrollment target (385% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01538056, a NA study of Abdominal Aortic Aneurysms, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

The primary objectives of this study are to determine whether physician modified endovascular grafts (PMEG) and specified company manufactured investigational devices are a safe and effective method of treating patients with elective, symptomatic or ruptured juxtarenal aortic aneurysms in those patients considered to have limited or no other options for treatment. Secondary objectives include the validation of a patient-specific, 3-D printed aortic template as a surgical planning tool for fenestrated endografting.

Primary Outcome

The safety of physician modified endovascular grafts will be determined by evaluating the proportion of patients that experience a rate of Major Adverse Events.

Conditions Studied

Interventions

  • DEVICE Fenestrated Endovascular Graft or Company Manufactured Terumo Aortic Fenestrated TREO Endovascular Graft

Study Locations (1)

Washington

  • Harborview Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2011-03
Est. Completion 2055-01
Phase NA
University of Washington

1,048 total trials

What NCT01538056 shows while recruiting

NCT01538056 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 103-participant average among 5 other Abdominal Aortic Aneurysms trials with a reported enrollment target (385% higher).

The record links to 1 condition, with Abdominal Aortic Aneurysms appearing as the primary indexed condition, and to 1 intervention - of which Fenestrated Endovascular Graft or Company Manufactured Terumo Aortic Fenestrated TREO Endovascular Graft is the first listed.

NCT01538056 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT01538056 about?

NCT01538056 is a clinical study titled "Physician Modified Endovascular Grafts". The primary objectives of this study are to determine whether physician modified endovascular grafts (PMEG) and specified company manufactured investigational devices are a safe and effective method of treating patients with elective, symptomatic or ruptured juxtarenal aortic aneurysms in those pati...

What is the current status of trial NCT01538056?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2011-03. Estimated completion is 2055-01.

What conditions does trial NCT01538056 study?

This clinical trial studies the following conditions: Abdominal Aortic Aneurysms.

What interventions are being tested in trial NCT01538056?

The interventions under investigation include: Fenestrated Endovascular Graft or Company Manufactured Terumo Aortic Fenestrated TREO Endovascular Graft (DEVICE).

Who is sponsoring clinical trial NCT01538056?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01538056 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abdominal Aortic Aneurysms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01538056, the US trial registry maintained by the National Library of Medicine. NCT01538056 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.